Long Term Follow-up Hybrid Revascularization

Coronary Artery Disease Clinical Trial

Official title:

Long Term Follow-up of Robotic Hybrid Surgical Revascularization With CT Angiography

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01955330
• Other study ID #: Kiaii-LTFUP-Hybrid-2013
• Secondary ID: REB #15000
• Status: Completed
• Start date: September 2013
• Est. completion date: September 2018

Study information

• Verified date: November 2018
• Source: Lawson Health Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

OBJECTIVES:

The objectives of the year study are two-fold:

1. To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI.

2. To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery

Description:

New techniques such as robotically-assisted Hybrid CABG surgery need proper evaluation to ensure potential benefits gained are not harmful to that which we know to be of significant benefit to the patients, that being the left internal thoracic artery (LITA) graft (one of the main coronary arteries supplying your heart with blood). We are therefore proposing a 5-7 year CT-Angiography (CTA) and Myocardial Perfusion Scintigraphy (MPS-MIBI) to assess the patency rate of the LITA graft and the stented graft in patients that have already undergone robotically assisted Hybrid CABG.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 2018
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.

Exclusion Criteria:

• Patients not described above

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

Intervention

Procedure:
• Robotic Hybrid coronary artery revascularization
Lita to LAD performed by robot, Hybrid stent to other diseased coronary artery

Locations

Country	Name	City	State
Canada	London Health Sciences Centre, University & Victoria Hospitals	London	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Lawson Health Research Institute	London Health Sciences Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Graft patency	To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.	5-7 years post Hybrid surgery